What are the current guidelines on the use of implantable defibrillators in transportation safety critical work?

Journal of Occupational and Environmental Medicine

Volumn 47, Issue 7, 2005, Pages 752-755

  Hartenbaum, Natalie P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; DEFIBRILLATOR; DRIVER; ELECTROMAGNETIC FIELD; FITNESS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; MORTALITY; OCCUPATIONAL SAFETY; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL; TREATMENT INDICATION;

EID: 22444450773     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000169527.90294.64     Document Type: Article

References (27)

1. Blumenthal R, Braunstein J, Connolly H, Epstein A, Gersh BJ, Wittels EH. Cardiovascular Advisory Panel Guidelines for the Medical Examination of Commercial Motor Vehicles Drivers. FMCSA-MCP-02-002. Washington, DC: US Department of Transportation, Federal Motor Carrier Safety Administration, FMCSA-MCP-02-002; October 2002.
2. Ahmad M. Patient's attitudes toward implanted defibrillator shocks. Pacing Clin Electrophysiol. 2000;23:931-933.
3. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337:1576-1583.
4. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS); a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000; 101:1297-1302.
5. Kuck KH, Cappato R, Siebels J, Puppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from cardiac arrest; the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000; 102:748-754.
6. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials; AVID, CASH, and CIDS studies. Eur Heart J. 200;21:2071-2078.
7. DiMarco JP. N Engl J Med. 2003;349: 1836-1847.
8. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. 2002;346: 877-883.
9. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention; a systemic review of randomized, controlled trials. Ann Intern Med. 2002;138: 445-452.
10. Goldman S, Johnson G, Cohn J, et al. Mechanisms of death in heart failure. Circulation. 1993;87:V124-V131.
11. Canadian Medical Association. Determining Medical Fitness to Drive, A Guide for Physicians, 6th ed. Ottawa: Canadian Medical Association; 2000. Available at: http://www.cma.ca/catalog/driversguide/index.htm, http://www. cma.ca/index.cfm/ci_id/18223/la_id/1.htm. Accessed October 12, 2004.
12. Maisel WH, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillators. JAMA. 2001;286:793-799.
13. Sears SF, et al. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. PACE. 2000;23: 939-945.
14. Chiladakis JA, Daviouros P, Agelopoulos G, et al. In-vivo testing of digital cellular telephones in patients with implantable cardioverter- defibrillators. Eur Heart J. 2001;22:1337-1342.
15. Rao BH, Saksena S. Implantable cardioverter-defibrillators in cardiovascular care; technologic advances and new indications. Curr Opin Crit Care. 2003;9: 362-368.
16. Fetch MC. Driving and heart disease-task force report. Eur Heart J. 1998;19: 1165-1177.
17. Akiyama T, Powell JL, Mitchell LB, Ehlert FA. Resumption of driving after life-threatening ventricular tachyarrhythmia. N Engl J Med. 2001;345:391-397.
18. Peters RW, Gold MR. Cardiac arrhythmias: implantable cardiac defibrillators. Med Clin North Am. 2001;85.
19. Golob MH, Seeger JJ. Current status of the implantable cardioverter-defibrillator. Chest. 2001;119:1210-1221.
20. Austroad. Assessing fitness to driver; for commercial and private vehicle drivers, 3rd ed. 2003. Available at: http://www. austroads.com.au/pdf/ AFTD_2003.pdf. Accessed October 12, 2004.
21. Canadian Medical Association. Determining Medical Fitness to Drive, A Guide for Physicians, 6th ed. Ottawa: Canadian Medical Association 2000. Available at: http://www.cma.ca/catalog/ driversguide/index.htm, http://www. cma.ca/index.cfm/ci_id/18223/la_id/ 1.htm. Accessed October 12, 2004.
22. Drivers Medical Group. For medical practitioners, At a glance guide to the current medical standards of fitness to drive. Swansea: Driver and Vehicle Licensing Agency, September 2004. Available at: http://www.dvla.gov. uk/at_a_glance/AAG2004sep.pdf. Accessed October 12, 2004.
23. Guide for Aviation Medical Examiner. Last updated March 19, 2004. Available at: http://www.faa.gov/avr/aam/ Game/Version_2/03amemanual/WEB/ AME_Guide_2004_1.pdf. Accessed October 9, 2004.
24. Railway Association of Canada. Canadian railway medical rules handbook (for positions critical to safe railway operations). 2001 Available at: http://www.railcan. ca/documents/publications/2003_0404_ CanadianMedicalRulesHandbook_en.pdf. Accessed October 8, 2004.
25. Code of Practice for Health Assessment of Rail Safety Workers Volume 2: Assessment Procedures and Medical Criteria, 2nd ed: 1 July 2004. Available at: http://www.doi. vic.gov.au/doi/internet/transport.nsf/alldocs/ 56ccbf1dc25de04cca256d4100836c70# adoption. Accessed October 8, 2004.
26. UIMC. Recommendations for the medical fitness of personnel with safety functions, Union internationale des Services Medicaux des Chemins de fer (UIMC) Interoperability Working Group?
27. National Transportation Safety Board. Factual Report-Aviation. NTSB ID number: MIA03LA182. Available at: http://www.ntsb.gov/NTSB/GenPDF. asp?id = MIA03LA182&rpt = fa. Accessed October 12, 2004.